Read the Registration Document - Guerbet

More documents

Recommendations

Info

III) Notes to the financial statementsNote 1 – Financial assets2012Available-forsalesecuritiesOriginated loansand receivablesFinancial assetsmeasured atfair valuethrough profitor lossTotal balancesheetNon-current tax receivables 1 - 832 - 832Other non-current financial assets 118 2,250 - 2,368Trade and other receivables - 86,826 - 86,826Other current financial assets - 20,235 - 20,235Cash and cash equivalents - - 10,473 10,473Total 118 110,143 10,473 120,7342011Available-forsalesecuritiesOriginated loansand receivablesFinancial assetsmeasured atfair valuethrough profitor lossTotal balancesheetNon-current tax receivables 2 - 5,376 - 5,376Other non-current financial assets 117 2,097 - 2,214Trade and other receivables - 85,254 - 85,254Other current financial assets - 14,699 - 14,699Cash and cash equivalents - - 7,872 7,872Total 117 107,426 7,872 115,415Change in financial assets depreciation31/12/2011 Allowances ReversalsCurrencytranslationadjustments31/12/2012Non-current tax receivables - - - - -Other non-current financial assets - - - - -Trade and other receivables 2,687 652 (1,560) (10) 1,769Current derivative financialinstruments-Other current financial assets 29 900 - (64) 865Cash and cash equivalents -Total 2,716 1,552 (1,560) (74) 2,6341 Of which discounted receivables for Research Tax Credits of 2010, 2011 and 2012 for €160,000, €216,000 and €442,000 andrepayable no later than 2014, 2015 and 2016 respectively.2 Of which a discounted receivable for a carry-back of €2,027,000 (repayable no later than 2016) as well as discounted receivables for2010 and 2011 research tax credits of €2,698,000 and €651,000, repayable no later than respectively 2014 and 2015.83
31/12/2010 Allowances ReversalsCurrencytranslationadjustments31/12/2011Non-current tax receivables - - - - -Other non-current financial assets - - - - -Trade and other receivables 1,740 2,099 (1,215) 63 2,687Current derivative financialinstruments- - - - -Other current financial assets 29 - - - 29Cash and cash equivalents - - - - -Total 1769 2,099 (1,215) 63 2,7161.1 – Originated loans and receivables at amortised cost2012 2011Cost Depreciation Net Cost Depreciation NetNon-current tax receivables 832 832 5,376 5,376Other non-current financial assets 2,250 2,250 2,097 2,097Trade and other receivables 88,595 (1,769) 86,826 87,941 (2,687) 85,254Other current financial assets 21,100 (865) 20,235 14,728 (29) 14,699Total 112,777 (2,634) 110,143 110,142 (2,716) 107,426Other current financial assets at amortised cost 2012 2011Advances and down-payments to suppliers 504 535Tax receivables (other than on income) 15,255 10,469Trade receivables 826 204Employee- related receivables 239 300Royalty payment receivables 4 10Grant receivables 1,253 -Other current assets 404 811Prepaid expenses 1,750 2,370Total 20,235 14,699Aged trial balance information for trade receivables at 31 December2012Cost Depreciation NetReceivables not due 72,236 (214) 72,022Receivables past due less than 3 months 10,493 (52) 10,441Receivables past due less than 6 months 2,489 (63) 2,426Receivables past due less than 1 year 1,699 (197) 1,502Receivables past due less than 2 years 1,302 (882) 420Receivables past due more than 2 years 376 (361) 15Total 88,595 (1,769) 86,826Outstanding trade receivables at 31 December 2012 were reduced by a non-recourse assignment in Italy inDecember 2012 for €2,921,000.84
Page 3 and 4:
CONTENTSCHIEF EXECUTIVE OFFICERS’
Page 5 and 6:
CHIEF EXECUTIVE OFFICERS’ MESSAGE
Page 7 and 8:
THE GUERBET GROUP1) History of the
Page 9 and 10:
3) Business overview3.1 Guerbet is
Page 11 and 12:
3.4 The pathologiesIn Oncology, the
Page 13:
Guerbet's offering of products is c
Page 16 and 17:
c) Research & development• R&D ob
Page 18 and 19:
• A proactive partnering strategy
Page 20 and 21:
5) Group organisation at 31 Decembe
Page 22 and 23:
e) DistributionGuerbet distribute i
Page 24 and 25:
DirectorsOther offices and director
Page 26 and 27:
There exist no arrangements or unde
Page 28 and 29:
Summary of compensation for Marie-C
Page 30 and 31:
• Stock options granted to non-of
Page 32 and 33:
I - 1Organisation of the work of th
Page 34 and 35: "Research and Innovation" Committee
Page 36 and 37: II - Internal control and risk mana
Page 38 and 39: 4) Statutory Auditors’ report pre
Page 40 and 41: SHAREHOLDER INFORMATION1) The Guerb
Page 42 and 43: As at 31 December 2010SHARESVOTING
Page 44 and 45: considered to have automatically re
Page 46 and 47: 10) Provisions of the Articles of A
Page 48 and 49: c) Earnings highlightsIFRS(in thous
Page 50 and 51: g) OutlookStrongly focused on the n
Page 52 and 53: 3) Risk factorsThe company conducte
Page 54 and 55: • Sourcing risksGuerbet has an ex
Page 56 and 57: • Information technology risksAn
Page 58 and 59: • Five-year summary of consolidat
Page 60 and 61: • Other information included in t
Page 62 and 63: • Recruitment and dismissalsGuerb
Page 64 and 65: and employee savings. The goal is s
Page 66 and 67: • Measures adopted to promote emp
Page 68 and 69: ) Pollution and waste managementThe
Page 70 and 71: 3) Societal informationa) Territori
Page 72 and 73: • Consolidated income statementIn
Page 74 and 75: In thousands of euros• Statement
Page 76 and 77: Changes in standards and interpreta
Page 78 and 79: g) Research and development expendi
Page 80 and 81: Held to maturity investmentsHeld-to
Page 82 and 83: creation are recorded under "Other
Page 86 and 87: Aged trial balance information for
Page 88 and 89: 2.2 - Borrowings by currencyCurrenc
Page 90 and 91: 3.3 - Analysis of the sensitivity o
Page 92 and 93: Revenue2012European companiesfor th
Page 94 and 95: In 2005, the Group acquired for ¥5
Page 96 and 97: 6.2 - Analysis of property, plant a
Page 98 and 99: The change in the net value of inve
Page 100 and 101: 12.2 - Accrued employee benefitsa)
Page 102 and 103: Change in net liabilities of the pe
Page 104 and 105: 14.4 - Personnel by region at year-
Page 106 and 107: Note 22 - Research and development
Page 108 and 109: Note 25 - Related parties25.1 - Rel
Page 110 and 111: Note 27 - Basic earnings per share
Page 112 and 113: 2) Auditors’ report on the consol
Page 114 and 115: 3) Parent company financial stateme
Page 116 and 117: • Income statementIn thousands of
Page 118 and 119: • Statement of cash flowsIn milli
Page 120 and 121: c) Property, plant and equipmentPro
Page 122 and 123: Note 1 - Intangible assets1 - 1 - C
Page 124 and 125: Note 6 - Receivables by maturityCos
Page 126 and 127: Note 9 - Regulated provisionsInvest
Page 128 and 129: Note 13 - Sales by region2012 2011F
Page 130 and 131: Tax income or expense recorded in t
Page 132 and 133: Debt waiver agreements granted to a
Page 134 and 135:
Capital lease commitments relative
Page 136 and 137:
4) Auditors' report on the separate
Page 138 and 139:
5) Auditors' special report on rela
Page 140 and 141:
ORDINARY AND EXTRAORDINARY GENERAL
Page 142 and 143:
RESOLUTION THREE (Special report of
Page 144 and 145:
Extraordinary resolutionsRESOLUTION
Page 146 and 147:
3) Report of the Board of Directors
Page 148 and 149:
Application of legal provisions gov
Page 150 and 151:
• Tenth draft resolution: stock s
Page 152 and 153:
2) The Statutory Auditorsa) Statuto
Page 154 and 155:
6) Articles of association (selecte
Page 156 and 157:
7) 2013 shareholders calendarEventD
Page 158 and 159:
) Annual financial reportInformatio
show all

Read the Registration Document - Guerbet

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?